Skip to content

Clinical trials

Completed Thrombocythemia, Essential trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocythemia, Essential Status: Completed Country / region: Italy Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20053
20073
20081
20101
20113
20132
20141
20171
20181
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
Icahn School of Medicine at Mount Sinai3
Shire3
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)2
Italfarmaco2
Ronald Hoffman2
AOP Orphan Pharmaceuticals AG1
Constellation Pharmaceuticals1
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS1
Federico II University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocythemia, Essential21
Polycythemia Vera14
Primary Myelofibrosis14
Myeloproliferative Disorders9
Leukemia, Myeloid, Acute5
Blast Crisis4
Burkitt Lymphoma4
Hodgkin Disease4
Immunoblastic Lymphadenopathy4
Intraocular Lymphoma4

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.